ONCY - Oncolytics Biotech - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ONCY is currently covered by 4 analysts with an average price target of $5.04. This is a potential upside of $3.87 (330.77%) from yesterday's end of day stock price of $1.17.

Oncolytics Biotech's activity chart (see below) currently has 13 price targets and 23 ratings on display. The stock rating distribution of ONCY is 71.43% BUY and 28.57% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 12.5% with an average time for these price targets to be met of 67.5 days.

Highest price target for ONCY is $3, Lowest price target is $3, average price target is $3.

Most recent stock forecast was given by PATRICK TRUCCHIO from HC WAINWRIGHT on 20-May-2025. First documented stock forecast 16-Feb-2021.

Best performing analysts who are covering ONCY - Oncolytics Biotech:

John Newman Patrick Trucchio Jason Mccarthy Soumit Roy

Currently out of the existing stock ratings of ONCY, 5 are a BUY (71.43%), 2 are a HOLD (28.57%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

4 months 23 days ago
(20-May-2025)

0/7 (0%)

$3.99 (395.05%)

Hold

$9

4 months 28 days ago
(15-May-2025)

0/1 (0%)

$6.85 (318.60%)

Buy

$3

$1.8 (150.00%)

$3

7 months 4 days ago
(09-Mar-2025)

1/2 (50%)

$2.36 (368.75%)

270

Buy

$5

$3.8 (316.67%)

$5

2 years 3 months 21 days ago
(22-Jun-2023)

0/3 (0%)

$2.26 (82.48%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ONCY (Oncolytics Biotech) average time for price targets to be met?

On average it took 67.5 days on average for the stock forecasts to be realized with a an average price target met ratio 12.5

Which analyst has the current highest performing score on ONCY (Oncolytics Biotech) with a proven track record?

JOHN NEWMAN

Which analyst has the current lower performing score on ONCY (Oncolytics Biotech) with a proven track record?

SOUMIT ROY

Which analyst has the most public recommendations on ONCY (Oncolytics Biotech)?

John Newman works at CANACCORD and has 5 price targets and 4 ratings on ONCY

Which analyst is the currently most bullish on ONCY (Oncolytics Biotech)?

John Newman with highest potential upside - $3.8

Which analyst is the currently most reserved on ONCY (Oncolytics Biotech)?

Patrick Trucchio with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?